|
Expanded HIV testing in low-prevalence, high-income countries: a cost-effectiveness analysis for the United Kingdom |
Long EF, Mandalia R, Mandalia S, Alistar SS, Beck EJ, Brandeau ML |
|
|
Record Status This is an economic evaluation that meets the criteria for inclusion on NHS EED. Bibliographic details Long EF, Mandalia R, Mandalia S, Alistar SS, Beck EJ, Brandeau ML. Expanded HIV testing in low-prevalence, high-income countries: a cost-effectiveness analysis for the United Kingdom. PLOS ONE 2014; 9(4): e95735 Indexing Status Subject indexing assigned by NLM MeSH Adolescent; Adult; Anti-HIV Agents /economics /therapeutic use; Cost-Benefit Analysis; Developed Countries /economics; False Positive Reactions; Female; Great Britain /epidemiology; HIV Infections /diagnosis /economics /epidemiology; Health Care Costs /statistics & Humans; Incidence; Male; Mass Screening /economics; Middle Aged; Prevalence; Quality-Adjusted Life Years; Sensitivity and Specificity; Young Adult; numerical data AccessionNumber 22014018891 Date bibliographic record published 21/05/2014 |
|
|
|